RU2706693C2 - Вирусная вакцина и способы ее производства - Google Patents

Вирусная вакцина и способы ее производства Download PDF

Info

Publication number
RU2706693C2
RU2706693C2 RU2016114285A RU2016114285A RU2706693C2 RU 2706693 C2 RU2706693 C2 RU 2706693C2 RU 2016114285 A RU2016114285 A RU 2016114285A RU 2016114285 A RU2016114285 A RU 2016114285A RU 2706693 C2 RU2706693 C2 RU 2706693C2
Authority
RU
Russia
Prior art keywords
virus
mass
purified
japanese encephalitis
membrane
Prior art date
Application number
RU2016114285A
Other languages
English (en)
Russian (ru)
Other versions
RU2016114285A3 (zh
RU2016114285A (ru
Inventor
Кришна Мохан ВАДРЕВУ
Венкатесан РАМАСАМИ
Прасанна Кумар ДУВВУРУ
Original Assignee
Бхарат Байотек Интернэшнл Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бхарат Байотек Интернэшнл Лимитед filed Critical Бхарат Байотек Интернэшнл Лимитед
Publication of RU2016114285A publication Critical patent/RU2016114285A/ru
Publication of RU2016114285A3 publication Critical patent/RU2016114285A3/ru
Application granted granted Critical
Publication of RU2706693C2 publication Critical patent/RU2706693C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2016114285A 2013-09-14 2014-09-08 Вирусная вакцина и способы ее производства RU2706693C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN4135/CHE/2013 2013-09-14
PCT/IN2014/000585 WO2015059714A1 (en) 2013-09-14 2014-09-08 Emergency mode in a hybrid vehicle
IN4135CH2013 IN2013CH04135A (zh) 2013-09-14 2014-09-08

Publications (3)

Publication Number Publication Date
RU2016114285A RU2016114285A (ru) 2017-10-19
RU2016114285A3 RU2016114285A3 (zh) 2018-07-16
RU2706693C2 true RU2706693C2 (ru) 2019-11-20

Family

ID=52997726

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016114285A RU2706693C2 (ru) 2013-09-14 2014-09-08 Вирусная вакцина и способы ее производства

Country Status (6)

Country Link
CN (1) CN105744952A (zh)
AU (1) AU2014338520B2 (zh)
IN (1) IN2013CH04135A (zh)
PH (1) PH12016500500A1 (zh)
RU (1) RU2706693C2 (zh)
WO (1) WO2015059714A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017083286A1 (en) 2015-11-09 2017-05-18 University Of Notre Dame Particle size purification method and devices
CN109415696A (zh) 2016-05-25 2019-03-01 泰尔茂比司特公司 细胞扩增
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
EP3601521A2 (en) 2017-03-31 2020-02-05 Terumo BCT, Inc. Cell expansion
EP3703739A2 (en) 2017-11-03 2020-09-09 Takeda Vaccines, Inc. Zika vaccines and immunogenic compositions, and methods of using the same
AU2018375789B2 (en) 2017-11-30 2021-11-11 Takeda Vaccines, Inc. Method for inactivating Zika virus and related methods
EP3581646A1 (en) * 2018-06-15 2019-12-18 Themis Bioscience GmbH Integrated manufacturing and chromatographic system for virus production
CN111394321A (zh) * 2020-03-30 2020-07-10 无锡加莱克色谱科技有限公司 病毒颗粒纯化用超大孔径层析介质及其应用方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011762A1 (en) * 1997-08-28 1999-03-11 Cheil Jedang Corporation An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine
WO2010137036A2 (en) * 2009-05-25 2010-12-02 Panacea Biotec Ltd Novel japanese encephalitis vaccine and method of manufacturing the same
WO2012073257A2 (en) * 2010-11-30 2012-06-07 Bharat Biotech International Limited Vaccine formulation for prophylaxis and treatment of chandipura virus infections in mammals
WO2013130001A1 (en) * 2012-02-29 2013-09-06 Ge Healthcare Bio-Sciences Ab Method for endotoxin removal

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102100910B (zh) * 2009-12-21 2013-01-23 北京清大天一科技有限公司 一种生产病毒疫苗的方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011762A1 (en) * 1997-08-28 1999-03-11 Cheil Jedang Corporation An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine
WO2010137036A2 (en) * 2009-05-25 2010-12-02 Panacea Biotec Ltd Novel japanese encephalitis vaccine and method of manufacturing the same
WO2012073257A2 (en) * 2010-11-30 2012-06-07 Bharat Biotech International Limited Vaccine formulation for prophylaxis and treatment of chandipura virus infections in mammals
WO2013130001A1 (en) * 2012-02-29 2013-09-06 Ge Healthcare Bio-Sciences Ab Method for endotoxin removal

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BADAM L., In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus.J Commun Dis. 1997 Jun; 29(2):91-9. *
CHEN WR., et al., Genetic variation of Japanese encephalitis virus in nature.J Gen Virol. 1990 Dec;71 ( Pt 12):2915-22. *
SAKODA Y., et al., Purification of human and avian influenza viruses using cellulose sulfate ester (Cellufine Sulfate) *
SAKODA Y., et al., Purification of human and avian influenza viruses using cellulose sulfate ester (Cellufine Sulfate) in the process of vaccine production.Microbiol Immunol. 2012 Jul; 56(7):490-5. doi: 10.1111/j.1348-0421.2012.00468.x. *

Also Published As

Publication number Publication date
AU2014338520B2 (en) 2019-12-05
WO2015059714A8 (en) 2015-06-18
RU2016114285A3 (zh) 2018-07-16
IN2013CH04135A (zh) 2015-08-14
RU2016114285A (ru) 2017-10-19
WO2015059714A1 (en) 2015-04-30
AU2014338520A1 (en) 2016-03-31
PH12016500500A1 (en) 2016-06-13
CN105744952A (zh) 2016-07-06

Similar Documents

Publication Publication Date Title
RU2706693C2 (ru) Вирусная вакцина и способы ее производства
EP1427817B1 (de) Vermehrung von viren in zellkultur
EP1427815B1 (de) Verfahren zur grosstechnischen herstellung von impfstoffen
ES2653197T3 (es) Procedimiento para producir antígeno ortomixoviral y vacunas
CN107267466B (zh) 一种大规模生产猪伪狂犬病灭活疫苗的方法
US6149917A (en) Industrial production process for a vaccine against Japanese encephalitis virus and vaccine produced
WO2013154928A1 (en) Systems and methods of virus propagation in cell culture for vaccine manufacture
US20080193478A1 (en) Inactivated Poliomyelitis Vaccine Derived From Sabin Strain Of Polio Virus
US20210268405A1 (en) Method for producing recombinant adenovirus
CN103223163A (zh) Ipv-dpt疫苗
US9932562B2 (en) Drain down and re-feed of microcarrier bioreactor
CN116656628A (zh) 一种痘病毒载体疫苗的制备方法
KR20120027381A (ko) 일본뇌염 백신 및 그것의 제조 방법
KR102245547B1 (ko) 고밀도의 미정제 세포 배양 수거물의 정화를 위한 방법
CN105296438A (zh) 一种制备森林脑炎灭活疫苗的生产方法
KR101581228B1 (ko) 바이러스의 증식을 위한 ２-단계 온도 프로파일
CN102343087A (zh) 麻疹长-47株制备二倍体细胞减毒活疫苗及制备工艺
CN114272366B (zh) 一种制备人用乙型脑炎灭活疫苗的方法及疫苗
CN1513553B (zh) Vero细胞森林脑炎灭活疫苗
RU2683508C1 (ru) Штамм вируса для изготовления вакцинных препаратов против геморрагической лихорадки с почечным синдромом (варианты)
CN115305276A (zh) 一种去除病毒样本中支原体污染的方法